More
    Guided Solutions - Connecting Talent With Innovation/div>

    GlucoModicum ups manufacturing after positive data for needle-free CGM

    Finnish tech-maker GlucoModicum will be upping manufacturing efforts of its Talisman CGM device following strong clinical data.  The device combines magnetohydrodynamic (MHD) technology, advanced algorithms...

    Kardium raises $104M for pulsed field ablation system

    Kardium announced that it raised $104 million in a new financing round to support its Globe pulsed field ablation (PFA) system.Existing investor Fidelity Management...

    Amber Therapeutics secures $100m for mixed urinary incontinence implant

    In one of the biggest Series A funding rounds for a medtech company in Europe, UK-based Amber Therapeutics has raised $100m (£80m) to advance...

    Restor3D secures $70M in a Series A financing round

    Restor3d has successfully closed a funding round worth $70 million. The Series A funding round brought in $55 million and was led by private...

    Mesosil secures $2.2m to develop infection-fighting biomaterials for medical devices

    Toronto-based nanotechnology startup Mesosil has closed $2.2 million CAD in seed funding to ramp up its production and fuel its commercialization plans. Spun out of...

    Osteal raises $50m to bring joint infection drug/device combo to market

    Osteal Therapeutics has raised $50m in Series D financing, as the orthopaedic infection treatment specialist turns its eyes to a regulatory submission for its...

    BetaGlue adds €8m equity financing to €10m EIC accelerator award

    BetaGlue™ Therapeutics, a clinical-stage radiotherapy company developing novel products for the personalised treatment of solid tumour cancers today announces the closing of an €8m...

    Raydiant Oximetry oversubscribes series A $7.5m extension round

    Raydiant Oximetry, Inc., a clinical-stage medical device company that develops medical technologies to improve outcomes for mothers and babies during childbirth, announced that it...

    Axena Health adds over $9M in Series A funding for its Leva Female Incontinence solution

    Axena Health, a medical device company dedicated to advancing female pelvic health, has successfully raised an additional $9.4 million in its Series A...

    Latest articles